OBIO
Orchestra BioMed Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.08
+5.19%2
Insider buys (3m)
3
Insider sells (3m)
-$140.9K
Net value (3m)
+41.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 11, 2026 | Hochman David P · director, officer: See Remarks | F-InKind | 3,283 | $5.81 |
| Sep 8, 2026 | Hochman David P · director, officer: See Remarks | Purchase | 10,000 | $4.79 |
| Sep 2, 2026 | Sherman Darren · director, officer: See Remarks | Sale | 15,000 | $4.94 |
| Aug 28, 2026 | Aiello Joshua · officer: Principal Accounting Officer | F-InKind | 203 | $5.26 |
| Aug 28, 2026 | Taylor Andrew Lawrence · officer: Chief Financial Officer | F-InKind | 3,076 | $5.26 |
| Aug 28, 2026 | Sherman Darren · director, officer: See Remarks | F-InKind | 4,925 | $5.26 |
| Aug 28, 2026 | Sherman Darren · director, officer: See Remarks | Purchase | 2,000 | $5.33 |
| Aug 14, 2026 | Cleary Chris · director | F-InKind | 4,238 | $4.42 |
| Aug 14, 2026 | Pacitti David · director | F-InKind | 3,761 | $4.42 |
| Aug 14, 2026 | Fain Eric S · director | F-InKind | 5,145 | $4.42 |
| Aug 14, 2026 | Mack John Prosper · director | F-InKind | 4,885 | $4.42 |
| Aug 4, 2026 | Sherman Darren · director, officer: See Remarks | Sale | 15,000 | $4.09 |
| Jul 2, 2026 | Sherman Darren · director, officer: See Remarks | Sale | 15,000 | $4.27 |
| Jun 25, 2026 | Mack John Prosper · director | F-InKind | 3,510 | $0.00 |
| Jun 25, 2026 | Fain Eric S · director | A-Award | 17,327 | $0.00 |
| Jun 25, 2026 | Fain Eric S · director | F-InKind | 4,261 | $0.00 |
| Jun 25, 2026 | Fain Eric S · director | A-Award | 21,277 | $4.04 |
| Jun 25, 2026 | Pacitti David · director | A-Award | 17,327 | $0.00 |
| Jun 25, 2026 | Pacitti David · director | F-InKind | 3,784 | $0.00 |
| Jun 25, 2026 | Pacitti David · director | A-Award | 21,277 | $4.04 |
| Jun 25, 2026 | Cleary Chris · director | F-InKind | 3,510 | $0.00 |
| Jun 25, 2026 | Cleary Chris · director | A-Award | 42,553 | $4.04 |
| Jun 25, 2026 | Connealy Pamela Ann · director | A-Award | 17,327 | $0.00 |
| Jun 25, 2026 | Connealy Pamela Ann · director | A-Award | 21,277 | $4.04 |
| Jun 25, 2026 | Aryeh Jason · director | A-Award | 42,553 | $4.04 |
| Jun 25, 2026 | Mack John Prosper · director | A-Award | 34,653 | $0.00 |
| Jun 12, 2026 | Taylor Andrew Lawrence · officer: Chief Financial Officer | F-InKind | 36,352 | $4.02 |
| Jun 12, 2026 | Hochman David P · director, officer: See Remarks | F-InKind | 3,283 | $4.02 |
| Jun 2, 2026 | Hochman David P · director, officer: See Remarks | Purchase | 5,000 | $3.83 |
| Jun 2, 2026 | Sherman Darren · director, officer: See Remarks | Sale | 15,000 | $3.87 |
Institutional positioning
13F filings over the trailing two quarters
New 44Increased 46Reduced 29Sold out 13
| Filer | Action | Shares | Filed |
|---|---|---|---|
| RTW INVESTMENTS, LP | Increased | 9,556,063 | Aug 14, 2026 |
| RTW INVESTMENTS, LP | Unchanged | 8,306,063 | May 15, 2026 |
| PERCEPTIVE ADVISORS LLC | Unchanged | 5,037,906 | Aug 14, 2026 |
| PERCEPTIVE ADVISORS LLC | Reduced | 5,037,906 | May 29, 2026 |
| BlackRock, Inc. | Increased | 2,510,387 | Aug 7, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,204,319 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 2,022,916 | Aug 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 1,007,908 | Aug 12, 2026 |
| ALYESKA INVESTMENT GROUP, L.P. | Unchanged | 1,000,000 | May 15, 2026 |
| Alyeska Investment Group, L.P. | Unchanged | 1,000,000 | Aug 14, 2026 |
| PROPEL BIO MANAGEMENT, LLC | New Position | 896,701 | May 14, 2026 |
| Propel Bio Management, LLC | Unchanged | 896,701 | Aug 13, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 702,543 | May 15, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | New Position | 642,154 | Aug 13, 2026 |
| BLACKROCK, INC. | Increased | 635,714 | May 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 11, 2026